Beranda › Kanker Paru Non-Sel Kecil › Rhode Island › Providence
Uji klinis Kanker Paru Non-Sel Kecil di Providence, RI
12 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Providence (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Rhode Island Hospital, Providence
- Roger Williams Medical Center, Providence
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 1/2
- Research Site, Providence
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Menerima pesertaFase 1/2
- Rhode Island Hospital, East Providence · 2 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Lifespan Cancer Institute, Providence
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
Menerima pesertaFase 2
- Rhode Island Hospital, Providence
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Menerima pesertaFase 3
- Rhode Island Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- Women and Infants Hospital of Rhode Island, Providence
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Menerima pesertaFase 1
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Menerima pesertaFase 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Providence
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Menerima pesertaFase 2
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Menerima pesertaStudi observasional
- Rhode Island Hospital, Brown University, Providence
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Studi lain di Providence
- Kanker Ovarium15 studi
- Kanker Endometrium14 studi
- Obesitas14 studi
- Kanker (semua jenis)12 studi
- Penyakit Crohn12 studi
- Kolitis Ulseratif11 studi
- Kanker Payudara11 studi
- Leukemia Mieloid Akut10 studi
- Kanker Metastatik9 studi
- Kelebihan Berat Badan9 studi
- Penyakit Alzheimer8 studi
- Gangguan Penggunaan Alkohol (AUD)8 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.